HIPEC plus FLOT versus FLOT alone for gastric or GE junction cancer
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial compares two treatment approaches after your stomach/GE junction cancer has been treated with chemotherapy before surgery: adding a special heated bath into the abdomen (HIPEC) plus continuing the usual surgery plan. It aims to see if adding HIPEC lowers cancer coming back and improves outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed stomach or gastroesophageal junction adenocarcinoma that can be removed with surgery
- Your cancer treatment before study must be 3 to 6 cycles of FLOT chemotherapy
- You must not have had other chemo or targeted drugs before—only FLOT
- Your scans must show no distant spread (no metastases), and nearby organs must not be invaded
- A laparoscopy (small camera surgery) must not show cancer spread on the lining of the belly (peritoneal disease)
- Your heart, liver, kidneys, and blood tests must be good enough for major surgery and HIPEC
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial studies whether adding a heated chemotherapy procedure during surgery (HIPEC) before the main cancer treatment can lower the chance that stomach cancer returns in the belly. It is for people with advanced stomach cancer who are at higher risk of cancer coming back in the peritoneum (the lining of the abdomen).
This trial compares standard laparoscopic surgery for stomach cancer versus the same surgery plus HIPEC, which is heated chemotherapy placed in the abdomen during the operation. It aims to see if adding the heated chemotherapy improves outcomes for people with higher-stage stomach cancer.
This trial tests if adding heated chemotherapy (HIPEC) right after stomach cancer surgery can help people with locally advanced gastric cancer live longer. It's for patients whose cancer has not spread to other parts of the body and who are fit enough for major surgery.
This trial tests a treatment called HIPEC done during/around surgery after chemotherapy for advanced stomach (gastric) cancer. It may help patients live longer or have fewer cancer-related problems after the operation.
This trial tests a special type of chemotherapy that is heated and delivered directly into the belly during surgery (called HIPEC). It uses two drugs, cisplatin and paclitaxel, and is for people with stomach cancer who are at high risk of the cancer returning in the lining of the belly.
This study tests whether a specialized surgery called HIPEC (heat-treated chemotherapy placed in the belly) can improve outcomes for people with advanced stomach cancer that has reached the lining of the abdomen. It’s given after you’ve already had standard chemotherapy, aiming to better control disease in the belly.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.